NK

Nisha Kumari

Active Director Director DIN 10091773
DIN 10091773 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Nisha Kumari

Data last updated:

Nisha Kumari is a Director at Niyash Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Niyash Pharmaceuticals Private Limited reported revenue of ₹78,229 (FY 2025).

DIN 10091773
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2023
Oldest Company Age 3 yrs
Largest company Niyash Pharmaceuticals Private Limited · ₹78,229 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Mar 20232023₹78,229 (FY 2025)Active

Board colleagues of Nisha Kumari

NameDINCompanyDesignation
Yashwant Kumar10091772Niyash Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Niyash Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nisha Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nisha Kumari

Nisha Kumari currently holds 1 directorship: Niyash Pharmaceuticals Private Limited (Director, since 28 Mar 2023, revenue ₹78,229 (FY 2025)).

Nisha Kumari was first appointed on 28 Mar 2023 as Director at Niyash Pharmaceuticals Private Limited.

The current boards of Nisha Kumari's companies include Yashwant Kumar (Niyash Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available